These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Acute Myocarditis Following COVID-19 mRNA Vaccination in Adults Aged 18 Years or Older. Simone A; Herald J; Chen A; Gulati N; Shen AY; Lewin B; Lee MS JAMA Intern Med; 2021 Dec; 181(12):1668-1670. PubMed ID: 34605853 [TBL] [Abstract][Full Text] [Related]
48. A Public Health COVID-19 Vaccination Strategy to Maximize the Health Gains for Every Single Vaccine Dose. Barnabas RV; Wald A Ann Intern Med; 2021 Apr; 174(4):552-553. PubMed ID: 33395339 [TBL] [Abstract][Full Text] [Related]
49. Association of Nursing Home Characteristics With Staff and Resident COVID-19 Vaccination Coverage. McGarry BE; Shen K; Barnett ML; Grabowski DC; Gandhi AD JAMA Intern Med; 2021 Dec; 181(12):1670-1672. PubMed ID: 34529009 [TBL] [Abstract][Full Text] [Related]
50. SARS-CoV-2 mRNA Vaccines Elicit Different Responses in Immunologically Naïve and Pre-Immune Humans. Forgacs D; Jang H; Abreu RB; Hanley HB; Gattiker JL; Jefferson AM; Ross TM Front Immunol; 2021; 12():728021. PubMed ID: 34646267 [TBL] [Abstract][Full Text] [Related]
51. Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial. Wu S; Huang J; Zhang Z; Wu J; Zhang J; Hu H; Zhu T; Zhang J; Luo L; Fan P; Wang B; Chen C; Chen Y; Song X; Wang Y; Si W; Sun T; Wang X; Hou L; Chen W Lancet Infect Dis; 2021 Dec; 21(12):1654-1664. PubMed ID: 34324836 [TBL] [Abstract][Full Text] [Related]
52. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Zhang Y; Zeng G; Pan H; Li C; Hu Y; Chu K; Han W; Chen Z; Tang R; Yin W; Chen X; Hu Y; Liu X; Jiang C; Li J; Yang M; Song Y; Wang X; Gao Q; Zhu F Lancet Infect Dis; 2021 Feb; 21(2):181-192. PubMed ID: 33217362 [TBL] [Abstract][Full Text] [Related]
53. BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers. Lustig Y; Sapir E; Regev-Yochay G; Cohen C; Fluss R; Olmer L; Indenbaum V; Mandelboim M; Doolman R; Amit S; Mendelson E; Ziv A; Huppert A; Rubin C; Freedman L; Kreiss Y Lancet Respir Med; 2021 Sep; 9(9):999-1009. PubMed ID: 34224675 [TBL] [Abstract][Full Text] [Related]
54. COVID-19 Vaccines: Preparing for Vaccination in the Context of Clinical Oncology Care. Carr E Clin J Oncol Nurs; 2021 Feb; 25(1):76-84. PubMed ID: 33480870 [TBL] [Abstract][Full Text] [Related]
55. Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination. Widge AT; Rouphael NG; Jackson LA; Anderson EJ; Roberts PC; Makhene M; Chappell JD; Denison MR; Stevens LJ; Pruijssers AJ; McDermott AB; Flach B; Lin BC; Doria-Rose NA; O'Dell S; Schmidt SD; Neuzil KM; Bennett H; Leav B; Makowski M; Albert J; Cross K; Edara VV; Floyd K; Suthar MS; Buchanan W; Luke CJ; Ledgerwood JE; Mascola JR; Graham BS; Beigel JH; N Engl J Med; 2021 Jan; 384(1):80-82. PubMed ID: 33270381 [No Abstract] [Full Text] [Related]
56. SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status - Los Angeles County, California, May 1-July 25, 2021. Griffin JB; Haddix M; Danza P; Fisher R; Koo TH; Traub E; Gounder P; Jarashow C; Balter S MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1170-1176. PubMed ID: 34437525 [TBL] [Abstract][Full Text] [Related]
57. Excess mortality in Cyprus during the COVID-19 vaccination campaign. Economidou EC; Soteriades ES Vaccine; 2024 May; 42(15):3375-3376. PubMed ID: 37996289 [No Abstract] [Full Text] [Related]
58. Guest Editorial: General practice and COVID-19: the journey to get vaccination experts involved. Murton S J Prim Health Care; 2021 Sep; 13(3):198-200. PubMed ID: 34588101 [No Abstract] [Full Text] [Related]